Rifabutin pharmacokinetics and safety among TB/HIV-coinfected children receiving lopinavir/ritonavir-containing second-line ART

The Journal of Antimicrombial Chemotherapy

Vol. 76, Issue 3, Pages 710-717

Date of Publication: February 2021

Authors:

Phyllis Kanki

Citations

Rawizza, Holly E et al. 2021. Rifabutin pharmacokinetics and safety among TB/HIV-coinfected children receiving lopinavir/ritonavir-containing second-line ART. The Journal of Antimicrombial Chemotherapy 76, no. 3 (February): 710-717.